Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma

by Albright, A., Ayers, M., Burtness, B., Cheng, J., Chow, L.Q.M, Cristescu, R., Eder, J.P, Gluck, I., Gupta, S., Haddad, R.I, Huang, L., Kang, H., Keam, B., Lunceford, J., Mehra, R., Mogg, R., Muro, K., Seiwert, T.Y, Tahara, M., Weiss, J.
Published 2022